论文部分内容阅读
A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome of
【机 构】
:
Department of Gastric Surgery,Fujian Medical University Union Hospital,No.29 Xinquan Road,Fuzhou 350
【出 处】
:
第十二届国际胃癌学术会议
【发表日期】
:
2017年4期
其他文献
Prognostic impact of tubular-papillar/poorly cohesive-Signet Ring Cell ratio in WHO mixed gastric ad
Local recurrence of a large gastric GIST despite adequate resection and adjuvant imatinib mesylate t
Critical analysis of the safety,short-term benefits and procedure-related morbidity of the Hyperther
The reduction of peripheral CD19+CD24h CD27+B cell frequency predicts clinical benefits in XELOX-tre
Survival outcomes of advanced gastric cancer patients who underwent neoadjuvant chemotherapy and gas
Influence of SLCO1B3 genetic polymorphisms on the incidence of adverse effects and trough plasma con
Background: Imatinib(Marketed as Glivec in USA and Gleevec in Europe)is a tyrosine kinase inhibitor(TKI),commonly used as a first-line therapy for treatment of Gastrointestinal Stromal Tumors(GIST)and
Background: TNM stage is based on the survival data of gastric cancer patients who underwent radical gastrectomy without neoadjuvant therapy.Whether it is fit for the patients after neoadjuvant chemot